About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [1,518 citations: 1–100 of 1,339 articles]

Articles published in Parkinson’s Disease have been cited 1,518 times. The following is a list of the 1,339 articles that have cited the articles published in Parkinson’s Disease.

  • Sinziana Mazilu, Ulf Blanke, Moran Dorfman, Eran Gazit, Anat Mirelman, Jeffrey M. Hausdorff, and Gerhard Tröster, “A Wearable Assistant for Gait Training for Parkinson’s Disease with Freezing of Gait in Out-of-the-Lab Environments,” ACM Transactions on Interactive Intelligent Systems, vol. 5, no. 1, pp. 1–31, 2015. View at Publisher · View at Google Scholar
  • Rıfat Emrah Özel, Akhtar Hayat, and Silvana Andreescu, “Recent Developments in Electrochemical Sensors for the Detection of Neurotransmitters for Applications in Biomedicine,” Analytical Letters, vol. 48, no. 7, pp. 1044–1069, 2015. View at Publisher · View at Google Scholar
  • Joanne Shanahan, Meg E. Morris, Orfhlaith Ni Bhriain, Jean Saunders, and Amanda M. Clifford, “Dance for People With Parkinson Disease: What Is the Evidence Telling Us?,” Archives Of Physical Medicine And Rehabilitation, vol. 96, no. 1, pp. 141–153, 2015. View at Publisher · View at Google Scholar
  • Christian Schlenstedt, Stephanie Brombacher, Gesa Hartwigsen, Burkhard Weisser, Bettina Moeller, and Guenther Deuschl, “Comparing the Fullerton Advanced Balance Scale With the Mini-BESTest and Berg Balance Scale to Assess Postural Control in Patients With Parkinson Dise,” Archives Of Physical Medicine And Rehabilitation, vol. 96, no. 2, pp. 218–225, 2015. View at Publisher · View at Google Scholar
  • Dana L. Dailey, Valerie J. Keffala, and Kathleen A. Sluka, “Do Cognitive and Physical Fatigue Tasks Enhance Pain, Cognitive Fatigue, and Physical Fatigue in People With Fibromyalgia?,” Arthritis Care & Research, vol. 67, no. 2, pp. 288–296, 2015. View at Publisher · View at Google Scholar
  • Aaron Kucinski, Roger L. Albin, Cindy Lustig, and Martin Sarter, “Modeling falls in Parkinson's disease: slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss,” Behavioural Brain Research, 2015. View at Publisher · View at Google Scholar
  • Yongle Li, Jun Zhang, and Chunxiang Yang, “UNC-51-like kinase 1 blocks S6k1 phosphorylation contributes to neurodegeneration in Parkinson’s disease model in vitro,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Jan Hejda, Ondrej Cakrt, Vladimir Socha, Jakub Schlenker, and Patrik Kutilek, “3-D trajectory of body sway angles: A technique for quantifying postural stability,” Biocybernetics and Biomedical Engineering, 2015. View at Publisher · View at Google Scholar
  • H. Zetterberg, G. E. Frykberg, J. Gäverth, and P. G. Lindberg, “Neural and Nonneural Contributions to Wrist Rigidity in Parkinson’s Disease: An Explorative Study Using the NeuroFlexor,” BioMed Research International, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Steno Rinalduzzi, Carlo Trompetto, Lucio Marinelli, Alessia Alibardi, Paolo Missori, Francesco Fattapposta, Francesco Pierelli, and Antonio Currà, “Balance Dysfunction in Parkinson’s Disease,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Douglas A. Wajda, and Jacob J. Sosnoff, “Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences,” BioMed Research International, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Alison Callahan, Juan Jose Cifuentes, and Michel Dumontier, “An evidence-based approach to identify aging-related genes in Caenorhabditis elegans,” Bmc Bioinformatics, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Gerwyn Morris, Michael Berk, Ken Walder, and Michael Maes, “Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses,” BMC Medicine, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Christina Tremblay, Joël Macoir, Mélanie Langlois, Léo Cantin, Michel Prud’homme, and Laura Monetta, “The effects of subthalamic deep brain stimulation on metaphor comprehension and language abilities in Parkinson’s disease,” Brain and Language, vol. 141, pp. 103–109, 2015. View at Publisher · View at Google Scholar
  • Li Li, Qiong Yu, and Weimin Liang, “Molecular pathways of mitochondrial dysfunctions: Possible cause of cell death in anesthesia-induced developmental neurotoxicity,” Brain Research Bulletin, vol. 110, pp. 14–19, 2015. View at Publisher · View at Google Scholar
  • Maria P. Bambo, Elena Garcia-Martin, Fernando Gutierrez-Ruiz, Juan Pinilla, Susana Perez-Olivan, Jose M. Larrosa, Vicente Polo, and Luis Pablo, “Analysis of optic disc color changes in Alzheimer's disease: a potential new biomarker,” Clinical Neurology and Neurosurgery, 2015. View at Publisher · View at Google Scholar
  • Marianne Amalric, “Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease,” Current Opinion in Pharmacology, vol. 20, pp. 29–34, 2015. View at Publisher · View at Google Scholar
  • Weidong Pan, Mingzhe Wang, Mao Li, Qiudong Wang, Shin Kwak, Wenfei Jiang, and Yoshiharu Yamamoto, “Actigraph Evaluation of Acupuncture for Treating Restless Legs Syndrome,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Thomas Müller, “The safety of istradefylline for the treatment of Parkinson’s disease,” Expert Opinion on Drug Safety, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Khaled Radad, Rudolf Moldzio, Mubarak Al-Shraim, Barbara Kranner, Christopher Krewenka, and Wolf-Dieter Rausch, “Recent advances in autophagy-based neuroprotection,” Expert Review of Neurotherapeutics, vol. 15, no. 2, pp. 195–205, 2015. View at Publisher · View at Google Scholar
  • George E. Barreto, Alexander Iarkov, and Valentina Echeverria Moran, “Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease,” Frontiers in Aging Neuroscience, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Chiara Monti, Heather Bondi, Andrea Urbani, Mauro Fasano, and Tiziana Alberio, “Systems biology analysis of the proteomic alterations induced by MPP+, a Parkinson's disease-related mitochondrial toxin,” Frontiers in Cellular Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Maria E. Figueiredo-Pereira, Patricia Rockwell, Thomas Schmidt-Glenewinkel, and Peter Serrano, “Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration,” Frontiers in Molecular Neuroscience, vol. 7, 2015. View at Publisher · View at Google Scholar
  • Lior Greenbaum, and Bernard Lerer, “Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes,” Frontiers in Neurology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Malav S. Trivedi, and Richard Deth, “Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention,” Frontiers in Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Sergio A. Salamanca, Edra E. Sorrentino, Joshua D. Nosanchuk, and Luis R. Martinez, “Impact of methamphetamine on infection and immunity,” Frontiers in Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Shinichi Amano, Deborah Kegelmeyer, and S. Lee Hong, “Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits,” Frontiers in Systems Neuroscience, vol. 8, 2015. View at Publisher · View at Google Scholar
  • Akari Minami, Atsuko Nakanishi, Satoru Matsuda, Yasuko Kitagishi, and Yasunori Ogura, “Function of alpha-synuclein and PINK1 in Lewy body dementia,” International Journal Of Molecular Medicine, vol. 35, no. 1, pp. 3–9, 2015. View at Publisher · View at Google Scholar
  • Speranza Rubattu, Beniamino Pagliaro, Giorgia Pierelli, Caterina Santolamazza, Sara Di Castro, Silvia Mennuni, and Massimo Volpe, “Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress,” International Journal Of Molecular Sciences, vol. 16, no. 1, pp. 823–839, 2015. View at Publisher · View at Google Scholar
  • Sara Marceglia, Elena Rossi, Manuela Rosa, Filippo Cogiamanian, Lorenzo Rossi, Laura Bertolasi, Alberto Vogrig, Francesco Pinciroli, Sergio Barbieri, and Alberto Priori, “Web-Based Telemonitoring and Delivery of Caregiver Support for Patients With Parkinson Disease After Deep Brain Stimulation: Protocol,” JMIR Research Protocols, vol. 4, no. 1, pp. e30, 2015. View at Publisher · View at Google Scholar
  • Matlou I. Mokgobu, Moloko C. Cholo, Ronald Anderson, Helen C. Steel, Maraki P. Motheo, Thembani N. Hlatshwayo, Gregory R. Tintinger, and Annette J. Theron, “Oxidative induction of pro-inflammatory cytokine formation by human monocyte-derived macrophages following exposure to manganese in vitro,” Journal Of Immunotoxicology, vol. 12, no. 1, pp. 98–103, 2015. View at Publisher · View at Google Scholar
  • Debapriya Garabadu, B. C. M. Harshavardhan Reddy, and Sairam Krishnamurthy, “Citalopram Protects Against Cold-Restraint Stress-Induced Activation of Brain-Derived Neurotrophic Factor and Expression of Nuclear Factor Kappa-Light,” Journal Of Molecular Neuroscience, vol. 55, no. 2, pp. 355–366, 2015. View at Publisher · View at Google Scholar
  • Sheila de Melo Borges, Márcia Radanovic, and Orestes Vicente Forlenza, “Functional Mobility in a Divided Attention Task in Older Adults With Cognitive Impairment,” Journal of Motor Behavior, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • José Christian Machado Ximenes, Kelly Rose Tavares Neves, Luzia Kalyne A. M. Leal, Marta Regina Santos do Carmo, Gerly Anne de Castro Brito, Maria da Graça Naffah-Mazzacoratti, Ésper Abrão Cavalheiro, and Glauce Socorro de Barros Viana, “Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson’s Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties,” Journal of Neurodegenerative Diseases, vol. 2015, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Allon Goldberg, Catherine L. Curtis, and Jeffrey A. Kleim, “Linking Genes to Neurological Clinical Practice: The Genomic Basis for Neurorehabilitation,” Journal Of Neurologic Physical Therapy, vol. 39, no. 1, pp. 52–61, 2015. View at Publisher · View at Google Scholar
  • Matt J. N. Brown, Quincy J. Almeida, and Fariborz Rahimi, “The dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD),” Journal Of Neurology, vol. 262, no. 1, pp. 41–53, 2015. View at Publisher · View at Google Scholar
  • Yasuhiro Tanaka, Takashi Tsuboi, Hirohisa Watanabe, Yasukazu Kajita, Yasushi Fujimoto, Reiko Ohdake, Noritaka Yoneyama, Michihito Masuda, Kazuhiro Hara, Joe Senda, Mizuki Ito, Naoki Atsuta, Satoshi Horiguchi, Masahiko Yamamoto, Toshihiko Wakabayashi, and Gen Sobue, “Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation,” Journal of Neurology, 2015. View at Publisher · View at Google Scholar
  • Richard G. Brown, and Bruce A. Fernie, “Metacognitions, anxiety, and distress related to motor fluctuations in Parkinson's disease,” Journal Of Psychosomatic Research, vol. 78, no. 2, pp. 143–148, 2015. View at Publisher · View at Google Scholar
  • Jason C. Dorman, Verle D. Valentine, Thayne A. Munce, B. Joel Tjarks, Paul A. Thompson, and Michael F. Bergeron, “Tracking postural stability of young concussion patients using dual-task interference,” Journal Of Science And Medicine In Sport, vol. 18, no. 1, pp. 2–7, 2015. View at Publisher · View at Google Scholar
  • Charles H. Brown, Candice Morrissey, Masahiro Ono, Gayane Yenokyan, Ola A. Selnes, Jeremy Walston, Laura Max, Andrew LaFlam, Karin Neufeld, Rebecca F. Gottesman, and Charles W. Hogue, “Impaired Olfaction and Risk of Delirium or Cognitive Decline After Cardiac Surgery,” Journal of the American Geriatrics Society, vol. 63, no. 1, pp. 16–23, 2015. View at Publisher · View at Google Scholar
  • Travis M. Cruickshank, Alvaro R. Reyes, and Melanie R. Ziman, “A Systematic Review and Meta-Analysis of Strength Training in Individuals With Multiple Sclerosis Or Parkinson Disease,” Medicine, vol. 94, no. 4, pp. e411, 2015. View at Publisher · View at Google Scholar
  • H. Zhang, C. Duan, and H. Yang, “Defective Autophagy in Parkinson's Disease: Lessons from Genetics,” Molecular Neurobiology, vol. 51, no. 1, pp. 89–104, 2015. View at Publisher · View at Google Scholar
  • Atsushi Tsujimura, Katsutoshi Taguchi, Yoshihisa Watanabe, Harutsugu Tatebe, Takahiko Tokuda, Toshiki Mizuno, and Masaki Tanaka, “Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous alpha-synuclein fibrils,” Neurobiology Of Disease, vol. 73, pp. 244–253, 2015. View at Publisher · View at Google Scholar
  • Mariza Bortolanza, Roberta Cavalcanti-Kiwiatkoski, Fernando E. Padovan-Neto, Celia Aparecida da-Silva, Miso Mitkovski, Rita Raisman-Vozari, and Elaine Del-Bel, “Glial activation is associated with L-DOPA induced dysldnesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease,” Neurobiology Of Disease, vol. 73, pp. 377–387, 2015. View at Publisher · View at Google Scholar
  • Zhiming Cui, Li Zhou, Chun Liu, Guanghui Zhu, Xinmin Wu, Yaohua Yan, Xiaopeng Xia, Zhiyun Ben, Yan Song, Ying Zhou, Haiyan Zhang, and Dongmei Zhang, “The Role of Homer1b/c in Neuronal Apoptosis Following LPS-Induced Neuroinflammation,” Neurochemical Research, vol. 40, no. 1, pp. 204–215, 2015. View at Publisher · View at Google Scholar
  • Deepti Putcha, Robert S. Ross, Alice Cronin-Golomb, Amy C. Janes, and Chantal E. Stern, “Altered intrinsic functional coupling between core neurocognitive networks in Parkinson's disease,” NeuroImage: Clinical, 2015. View at Publisher · View at Google Scholar
  • F. Martínez-Sánchez, J.J.G. Meilán, J. Carro, C. Gómez Íñiguez, L. Millian-Morell, I.M. Pujante Valverde, T. López-Alburquerque, and D.E. López, “Estudio controlado del ritmo del habla en la enfermedad de Parkinson,” Neurología, 2015. View at Publisher · View at Google Scholar
  • Werner Poewe, and Atbin Djamshidian-Tehrani, “Movement Disorders in Systemic Diseases,” Neurologic Clinics, vol. 33, no. 1, pp. 269–+, 2015. View at Publisher · View at Google Scholar
  • Thomas G. Beach, Charles H. Adler, Lucia I. Sue, Geidy Serrano, Holly A. Shill, Douglas G. Walker, LihFen Lue, Alex E. Roher, Brittany N. Dugger, Chera Maarouf, Alex C. Birdsill, Anthony Intorcia, Megan Saxon-Labelle, Joel Pullen, Alexander Scroggins, Jessica Filon, Sarah Scott, Brittany Hoffman, Angelica Garcia, John N. Caviness, Joseph G. Hentz, Erika Driver-Dunckley, Sandra A. Jacobson, Kathryn J. Davis, Christine M. Belden, Kathy E. Long, Michael Malek-Ahmadi, Jessica J. Powell, Lisa D. Gale, Lisa R. Nicholson, Richard J. Caselli, Bryan K. Woodruff, Steven Z. Rapscak, Geoffrey L. Ahern, Jiong Shi, Anna D. Burke, Eric M. Reiman, and Marwan N. Sabbagh, “Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program,” Neuropathology, 2015. View at Publisher · View at Google Scholar
  • Noha N. Nassar, Muhammad Y. Al-Shorbagy, Hany H. Arab, and Dalaal M. Abdallah, “Saxagliptin: A novel antiparkinsonian approach,” Neuropharmacology, vol. 89, pp. 308–317, 2015. View at Publisher · View at Google Scholar
  • Mirella Díaz-Santos, Bo Cao, Arash Yazdanbakhsh, Daniel J. Norton, Sandy Neargarder, and Alice Cronin-Golomb, “Perceptual, cognitive, and personality rigidity in Parkinson's disease,” Neuropsychologia, 2015. View at Publisher · View at Google Scholar
  • T. T. Vlagsma, J. Koerts, L. Fasotti, O. Tucha, T. van Laar, H. Dijkstra, and J. M. Spikman, “Parkinson's patients’ executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?,” Neuropsychological Rehabilitation, pp. 1–20, 2015. View at Publisher · View at Google Scholar
  • Xia Shen, and Margaret K. Y. Mak, “Technology-Assisted Balance and Gait Training Reduces Falls in Patients With Parkinson's Disease: A Randomized Controlled Trial With 12-Month Follow-u,” Neurorehabilitation And Neural Repair, vol. 29, no. 2, pp. 103–111, 2015. View at Publisher · View at Google Scholar
  • Janey Prodoehl, Miriam R. Rafferty, Fabian J. David, Cynthia Poon, David E. Vaillancourt, Cynthia L. Comella, Sue E. Leurgans, Wendy M. Kohrt, Daniel M. Corcos, and Julie A. Robichaud, “Two-Year Exercise Program Improves Physical Function in Parkinson's Disease: The PRET-PD Randomized Clinical Trial,” Neurorehabilitation And Neural Repair, vol. 29, no. 2, pp. 112–122, 2015. View at Publisher · View at Google Scholar
  • Farshid Mohammadi, Sjoerd M. Bruijn, Griet Vervoort, Erwin E. van Wegen, Gert Kwakkel, Sabine Verschueren, and Alice Nieuwboer, “Motor Switching and Motor Adaptation Deficits Contribute to Freezing of Gait in Parkinson's Disease,” Neurorehabilitation And Neural Repair, vol. 29, no. 2, pp. 132–142, 2015. View at Publisher · View at Google Scholar
  • H. Dong, R. Li, C. Yu, T. Xu, X. Zhang, and M. Dong, “PAEONIFLORIN INHIBITION OF 6-HYDROXYDOPAMINE-INDUCED APOPTOSIS IN PC12 CELLS VIA SUPPRESSING REACTIVE OXYGEN SPECIES-MEDIATED PKC delta/NF-kappa B PAT,” Neuroscience, vol. 285, pp. 70–80, 2015. View at Publisher · View at Google Scholar
  • G. Ramírez-García, V. Palafox-Sánchez, and I.D. Limón, “Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Samaneh Reiszadeh Jahromi, Mohammad Haddadi, T. Shivanandappa, and S.R. Ramesh, “Attenuation of Neuromotor Deficits by Natural Antioxidants of Decalepis hamiltonii in Transgenic Drosophila Model of Parkinson’s Disease,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Kate Greenwell, William K. Gray, Anna van Wersch, Paul van Schaik, and Richard Walker, “Predictors of the psychosocial impact of being a carer of people living with Parkinson's disease: A systematic review,” Parkinsonism & Related Disorders, vol. 21, no. 1, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • K. Amar, E. Stack, C. Fitton, A. Ashburn, and H. C. Roberts, “Fall frequency, predicting falls and participating in falls research: Similarities among people with Parkinson's disease with and without cognitive im,” Parkinsonism & Related Disorders, vol. 21, no. 1, pp. 55–60, 2015. View at Publisher · View at Google Scholar
  • Shih-Wei Lai, Cheng-Li Lin, Kuan-Fu Liao, and Kao-Chi Chang-Ou, “Increased risk of Parkinson's disease in cataract patients: A population-based cohort study,” Parkinsonism & Related Disorders, vol. 21, no. 1, pp. 68–71, 2015. View at Publisher · View at Google Scholar
  • Yair Zlotnik, Yacov Balash, Amos D. Korczyn, Nir Giladi, and Tanya Gurevich, “Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes,” Parkinson's Disease, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Khashayar Dashtipour, Eric Johnson, Camellia Kani, Kayvan Kani, Ehsan Hadi, Mark Ghamsary, Shant Pezeshkian, and Jack J. Chen, “Effect of Exercise on Motor and Nonmotor Symptoms of Parkinson’s Disease,” Parkinson's Disease, vol. 2015, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Ben Newland, Heike Newland, Carsten Werner, Anne Rosser, and Wenxin Wang, “Neurodegenerative Disorders,” Progress in Polymer Science, 2015. View at Publisher · View at Google Scholar
  • Sara Piccoli, Giulia Perini, Silvia Pizzighello, Alec Vestri, Giovanni Ferri, Tommaso Toffanin, Halima Follador, and Andrea Martinuzzi, “A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease,” Psychiatry Investigation, vol. 12, no. 1, pp. 146–149, 2015. View at Publisher · View at Google Scholar
  • M. Y. Goh, E. C. K. Wong, M. S. Millard, D. J. Brown, and C. J. O'Callaghan, “A retrospective review of the ambulatory blood pressure patterns and diurnal urine production in subgroups of spinal cord injured patients,” Spinal Cord, vol. 53, no. 1, pp. 49–53, 2015. View at Publisher · View at Google Scholar
  • A.P. Das, S. Ghosh, S. Mohanty, and L.B. Sukla, “Consequences of manganese compounds: a review,” Toxicological & Environmental Chemistry, pp. 1–17, 2015. View at Publisher · View at Google Scholar
  • P. Munoz, S. Cardenas, S. Huenchuguala, A. Briceno, E. Couve, I. Paris, and J. Segura-Aguilar, “DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity,” Toxicological Sciences, 2015. View at Publisher · View at Google Scholar
  • Danuta M Lisiecka, John Suckling, Thomas RE Barnes, Imran B Chaudhry, Paola Dazzan, Nusrat Husain, Peter B Jones, Eileen M Joyce, Stephen M Lawrie, Rachel Upthegrove, and Bill Deakin, “The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial,” Trials, vol. 16, no. 1, 2015. View at Publisher · View at Google Scholar
  • Gyan P Modi, Chandrashekhar Voshavar, Sanjib Gogoi, Mrudang Shah, Tamara Antonio, Maarten E. A. Reith, and Aloke K. Dutta, “Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: Modulator of toxicity of Alpha synuclein aggregates,” ACS Chemical Neuroscience, pp. 140624131824004, 2014. View at Publisher · View at Google Scholar
  • M. A. Hobert, W. Maetzler, K. Aminian, and L. Chiari, “Technical and clinical view on ambulatory assessment in Parkinson's disease,” Acta Neurologica Scandinavica, vol. 130, no. 3, pp. 139–147, 2014. View at Publisher · View at Google Scholar
  • Veronica Bisagno, and Christopher Mark Milroy, “Neuropathology of substance use disorders,” Acta Neuropathologica, vol. 127, no. 1, pp. 91–107, 2014. View at Publisher · View at Google Scholar
  • Silke Nuber, Daniel Tadros, Jerel Fields, Cassia Rose Overk, Benjamin Ettle, Kori Kosberg, Michael Mante, Edward Rockenstein, Margarita Trejo, and Eliezer Masliah, “Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD,” Acta Neuropathologica, vol. 127, no. 4, pp. 477–494, 2014. View at Publisher · View at Google Scholar
  • Md Sarwar Jahan, Mohd Nozulaidi, Mohammad Moneruzzaman Khandaker, Ainun Afifah, and Nurul Husna, “Control of plant growth and water loss by a lack of light-harvesting complexes in photosystem II in Arabidopsis thaliana ch1-1 mutant,” Acta Physiologiae Plantarum, vol. 36, no. 7, pp. 1627–1635, 2014. View at Publisher · View at Google Scholar
  • Hao Deng, and Lamei Yuan, “Genetic variants and animal models in SNCA and Parkinson disease,” Ageing Research Reviews, 2014. View at Publisher · View at Google Scholar
  • Nancy Monroy-Jaramillo, Jorge Luis Guerrero-Camacho, Mayela Rodríguez-Violante, Marie-Catherine Boll-Woehrlen, Petra Yescas-Gómez, María Elisa Alonso-Vilatela, and Marisol López-López, “Genetic mutations in early-onset Parkinson's disease Mexican patients: Molecular testing implications,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014. View at Publisher · View at Google Scholar
  • Sherrilene Classen, Babette Brumback, Miriam Monahan, Irene I. Malaty, Ramon L. Rodriguez, Michael S. Okun, and Nikolaus R. McFarland, “Driving Errors in Parkinson's Disease: Moving Closer to Predicting On-Road Outcomes,” American Journal of Occupational Therapy, vol. 68, no. 1, pp. 77–85, 2014. View at Publisher · View at Google Scholar
  • Benjamin J. Kim, Gui-Shuang Ying, Jiayan Huang, Nicole E. Levy, and Maureen G. Maguire, “Sporadic Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT),” American Journal of Ophthalmology, vol. 158, no. 1, pp. 128–135, 2014. View at Publisher · View at Google Scholar
  • Gavin Williams, Michelle Kahn, and Alana Randall, “Strength Training for Walking in Neurologic Rehabilitation Is Not Task Specific A Focused Review,” American Journal of Physical Medicine & Rehabilitation, vol. 93, no. 6, pp. 511–522, 2014. View at Publisher · View at Google Scholar
  • Ainsley M. Robinson, Samy Sakkal, Anthony Park, Valentina Jovanovska, Natalie Payne, Simona E. Carbone, Sarah Miller, Joel C. Bornstein, Claude Bernard, Richard Boyd, and Kulmira Nurgali, “Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis,” American Journal Of Physiology-Gastrointestinal And Liver Physiology, vol. 307, no. 11, pp. G1115–G1129, 2014. View at Publisher · View at Google Scholar
  • B. R. Amar, Ravi Yadav, Y. C. Janardhan Reddy, and Pramod Kumar Pal, “A clinical profile of patients with Parkinson's disease and psychosis,” Annals of Indian Academy of Neurology, vol. 17, no. 2, pp. 187–192, 2014. View at Publisher · View at Google Scholar
  • Sarah A. Eisenstein, Jonathan M. Koller, Kathleen D. Black, Meghan C. Campbell, Heather M. Lugar, Mwiza Ushe, Samer D. Tabbal, Morvarid Karimi, Tamara Hershey, Joel S. Perlmutter, and Kevin J. Black, “Functional Anatomy of Subthalamic Nucleus Stimulation in Parkinson Disease,” Annals of Neurology, vol. 76, no. 2, pp. 279–295, 2014. View at Publisher · View at Google Scholar
  • Nigel H. Greig, Kumar Sambamurti, Debomoy K. Lahiri, and Robert E. Becker, “Amyloid-beta Precursor Protein Synthesis Inhibitors for Alzheimer's Disease Treatment,” Annals of Neurology, vol. 76, no. 4, pp. 629–630, 2014. View at Publisher · View at Google Scholar
  • Ai Yamamoto, and Zhenyu Yue, “Autophagy and Its Normal and Pathogenic States in the Brain,” Annual Review of Neuroscience, vol. 37, no. 1, pp. 55–78, 2014. View at Publisher · View at Google Scholar
  • Nele A. Haelterman, Wan Hee Yoon, Hector Sandoval, Manish Jaiswal, Joshua M. Shulman, and Hugo J. Bellen, “A Mitocentric View of Parkinson's Disease,” Annual Review of Neuroscience, vol. 37, no. 1, pp. 137–159, 2014. View at Publisher · View at Google Scholar
  • Neena Singh, Swati Haldar, Ajai K. Tripathi, Katharine Horback, Joseph Wong, Deepak Sharma, Amber Beserra, Srinivas Suda, Charumathi Anbalagan, Som Dev, Chinmay K. Mukhopadhyay, and Ajay Singh, “Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities,” Antioxidants & Redox Signaling, vol. 20, no. 8, pp. 1324–1363, 2014. View at Publisher · View at Google Scholar
  • Ji Hye Park, Vernon Hodge, Shawn Gerstenberger, and Krystyna Stave, “Mobilization of Toxic Elements from an Abandoned Manganese Mine in the Arid Metropolitan Las Vegas (NV, USA) Area,” Applied Sciences-Basel, vol. 4, no. 2, pp. 240–254, 2014. View at Publisher · View at Google Scholar
  • Paraskevi Kourtidou, Dimitrios Kasselimis, Constantin Potagas, Ioannis Zalonis, and Ioannis Evdokimidis, “Dissociating Between the Effects of Mental Flexibility and Motor Dysfunction on Cognitive Performance in Patients With Parkinson's Disease,” Archives of Neuroscience, vol. 2, no. 3, 2014. View at Publisher · View at Google Scholar
  • Elizabeth L. Stegemoeller, Joe Nocera, Irene Malaty, Mack Shelley, Michael. S. Okun, and Chris J. Hass, “Timed Up and Go, Cognitive, and Quality-of-Life Correlates in Parkinson's Disease,” Archives of Physical Medicine and Rehabilitation, vol. 95, no. 4, pp. 649–655, 2014. View at Publisher · View at Google Scholar
  • Margaret K. Mak, Adrian Wong, and Marco Y. Pang, “Impaired Executive Function Can Predict Recurrent Falls in Parkinson's Disease,” Archives Of Physical Medicine And Rehabilitation, vol. 95, no. 12, pp. 2390–2395, 2014. View at Publisher · View at Google Scholar
  • Elizabeth L. Proud, Kimberly J. Miller, Belinda Bilney, Sulakshana Balachandran, Jennifer L. McGinley, and Meg E. Morris, “Evaluation of Measures of Upper Limb Functioning and Disability in People With Parkinson Disease: A Systematic Review,” Archives of Physical Medicine and Rehabilitation, 2014. View at Publisher · View at Google Scholar
  • Francesco Cordici, Carmelo Genovese, and Placido Bramanti, “Choline Associated Hypersexuality in a 79-Year-Old Man,” Archives of Sexual Behavior, vol. 43, no. 1, pp. 187–189, 2014. View at Publisher · View at Google Scholar
  • Jasvinder A. Singh, “Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study,” Arthritis Research & Therapy, vol. 16, no. 2, 2014. View at Publisher · View at Google Scholar
  • Soumyabrata Munshi, Vineet Kumar Khemka, Kalpita Banerjee, and Sasanka Chakrabarti, “Clinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease,” Asian Journal of Neuroscience, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Hermann Ackermann, Steffen R. Hage, and Wolfram Ziegler, “Brain mechanisms of acoustic communication in humans and nonhuman primates: An evolutionary perspective,” Behavioral And Brain Sciences, vol. 37, no. 6, pp. 529–604, 2014. View at Publisher · View at Google Scholar
  • Lay Khoon Too, James A. McQuillan, Helen J. Ball, Masaaki Kanai, Toshikazu Nakamura, Hiroshi Funakoshi, Iain S. McGregor, and Nicholas H. Hunt, “The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis,” Behavioural Brain Research, vol. 270, pp. 179–195, 2014. View at Publisher · View at Google Scholar
  • Janaina K. Barbiero, Ronise M. Santiago, Daniele Suzete Persike, Maria Jose da Silva Fernandes, Fernanda S. Tonin, Claudio da Cunha, Suelen Lucio Boschen, Marcelo M. S. Lima, and Maria A. B. F. Vital, “Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine,” Behavioural Brain Research, vol. 274, pp. 390–399, 2014. View at Publisher · View at Google Scholar
  • Alberto Costa, Antonella Peppe, Ilenia Mazzù, Mariachiara Longarzo, Carlo Caltagirone, and Giovanni A. Carlesimo, “Dopamine Treatment and Cognitive Functioning in Individuals with Parkinson’s Disease: The “Cognitive Flexibility” Hypothesis Seems to Work,” Behavioural Neurology, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Weidong Pan, Yu Song, Shin Kwak, Sohei Yoshida, and Yoshiharu Yamamoto, “Quantitative Evaluation of the Use of Actigraphy for Neurological and Psychiatric Disorders,” Behavioural Neurology, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Sanghamitra Bandyopadhyay, and Jack T. Rogers, “Azheimer's Disease Therapeutics Targeted to the Control of Amyloid Precursor Protein Translation: Maintenance of Brain Iron Homeostasis,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar